Share to

Overview

Specs

Technical Documents

Articles

reviews

Consult

returns

Product introduction

NYX-2925 is an orally active NMDAR modulator. NYX-2925 restores levels of activated Src and Src phosphorylation sites on GluN2A and GluN2B in the mPFC. NYX-2925 shows no effect on CAMKII, and any addictive or sedative/ataxic side effects. NYX-2925 can be used for research of a variety of NMDA receptor-mediated central nervous system disorders IC50& Target:NMDA Receptor

Specs ⸢ View details ⸥

Chinese name

NYX-2925

English name

NYX-2925

Chinese alias

English alias

2012536-16-0 | NYX2925 | NYX-2925 | 2,5-DIAZASPIRO(3.4)OCTANE-2-ACETAMIDE, .ALPHA.-((1R)-1-HYDROXYETHYL)-5-(2-METHYL-1-OXOPROPYL)-1-OXO-, (.ALPHA.S,4R)- | (2S,3R)-3-hydroxy-2-[(4R)-5-(2-methylpropanoyl)-3-oxo-2,5-diazaspiro[3.4]octan-2-yl]butanamide | X06

CAS number

2012536-16-0

molecular formula

C14H23N3O4

molecular weight

297.35 g/mol

Exact mass

PSA

Logp

Technical Documents

「No technical documents」

「No upstream and downstream information yet」

Articles

「No related articles yet」

user reviews

Consultation

Warm reminder：

Because the manufacturer may temporarily adjust product specifications, prices, inventory, parameters and other information without notice, and there are differences in each user's consultation time and procurement needs, the platform reply content is only of reference value within a certain period. Sorry for the inconvenience caused to you, and thank you for your understanding and support! Please consult the online customer service for the latest details. Everything is subject to the real-time reply of the customer service.！

After Sales Services

Please check the quantity, appearance and product information in time when you receive the goods. In case of damage, wrong delivery, abnormal quality and other problems, please feel free to contact us.

Service Hotline:400-6226-992 ，We will handle it for you as soon as possible, thank you for your support and trust.！